Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Anal cancer is a disease in which malignant (cancer) cells form in the tissues of the anus. Being infected with the human papillomavirus (HPV) increases the risk of developinganal cancer. Signs of anal cancer include bleeding from theanus or rectum or a lump near the anus.
The report details the trend, potential and market size of Anal Cancer market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Anal Cancermarket, defines the market attractiveness level of Anal Cancer market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Anal Cancer industry, describes the types of Anal Cancer market, the applications of major players and the market size, and deeply analyzes the current situation of the global Anal Cancer market and the development prospects and opportunities of Anal Cancer industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Anal Cancer market in Chapter 13.
By Player:
Spectrum Pharmaceuticals
PDS Biotechnology
GlaxoSmithKline
Oryx
Eli Lilly
??Ono Pharmaceutical
Hospira
ISA Pharmaceuticals
Advaxis
Novartis
Millennium Pharmaceuticals
Atara Biotherapeutics
Genticel
Bayer
Global BioPharma
Merck?Co
Sun Pharma
Cell Medica
Amgen Inc
By Type:
Fluorouracil
Cisplatin
Carboplatin
Other
By End-User:
Hospitals
Long-term care centers
Pharmacies
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Anal Cancer Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Anal Cancer Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Anal Cancer Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Anal Cancer Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Anal Cancer Market Analysis and Outlook to 2022
-
7.1 Global Anal Cancer Consumption (2017-2022)
-
7.2 United States Anal Cancer Consumption (2017-2022)
-
7.3 Europe Anal Cancer Consumption (2017-2022)
-
7.4 China Anal Cancer Consumption (2017-2022)
-
7.5 Japan Anal Cancer Consumption (2017-2022)
-
7.6 India Anal Cancer Consumption (2017-2022)
-
7.7 South Korea Anal Cancer Consumption (2017-2022)
8 Region and Country-wise Anal Cancer Market Analysis and Outlook to 2028
-
8.1 Global Anal Cancer Consumption Forecast (2022-2028)
-
8.2 United States Anal Cancer Consumption Forecast (2022-2028)
-
8.3 Europe Anal Cancer Consumption Forecast (2022-2028)
-
8.4 China Anal Cancer Consumption Forecast (2022-2028)
-
8.5 Japan Anal Cancer Consumption Forecast (2022-2028)
-
8.6 India Anal Cancer Consumption Forecast (2022-2028)
-
8.7 South Korea Anal Cancer Consumption Forecast (2022-2028)
9 Global Anal Cancer Market Outlook by Types and Applications to 2022
-
9.1 Global Anal Cancer Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Fluorouracil Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Cisplatin Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Carboplatin Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Other Consumption and Growth Rate (2017-2022)
-
9.2 Global Anal Cancer Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Long-term care centers Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Other Consumption and Growth Rate (2017-2022)
10 Global Anal Cancer Market Outlook by Types and Applications to 2028
-
10.1 Global Anal Cancer Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Fluorouracil Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Cisplatin Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Carboplatin Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Other Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Anal Cancer Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Long-term care centers Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Anal Cancer Import and Export Analysis (Top 5 Countries)
-
11.1 Global Anal Cancer Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Anal Cancer Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Anal Cancer Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Anal Cancer Market Competitive Analysis
-
14.1 Spectrum Pharmaceuticals
-
14.1.1 Spectrum Pharmaceuticals Company Details
-
14.1.2 Spectrum Pharmaceuticals Anal Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Spectrum Pharmaceuticals Anal Cancer Product and Service
-
14.2 PDS Biotechnology
-
14.2.1 PDS Biotechnology Company Details
-
14.2.2 PDS Biotechnology Anal Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 PDS Biotechnology Anal Cancer Product and Service
-
14.3 GlaxoSmithKline
-
14.3.1 GlaxoSmithKline Company Details
-
14.3.2 GlaxoSmithKline Anal Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 GlaxoSmithKline Anal Cancer Product and Service
-
14.4 Oryx
-
14.4.1 Oryx Company Details
-
14.4.2 Oryx Anal Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Oryx Anal Cancer Product and Service
-
14.5 Eli Lilly
-
14.5.1 Eli Lilly Company Details
-
14.5.2 Eli Lilly Anal Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Eli Lilly Anal Cancer Product and Service
-
14.6 ??Ono Pharmaceutical
-
14.6.1 ??Ono Pharmaceutical Company Details
-
14.6.2 ??Ono Pharmaceutical Anal Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 ??Ono Pharmaceutical Anal Cancer Product and Service
-
14.7 Hospira
-
14.7.1 Hospira Company Details
-
14.7.2 Hospira Anal Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Hospira Anal Cancer Product and Service
-
14.8 ISA Pharmaceuticals
-
14.8.1 ISA Pharmaceuticals Company Details
-
14.8.2 ISA Pharmaceuticals Anal Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 ISA Pharmaceuticals Anal Cancer Product and Service
-
14.9 Advaxis
-
14.9.1 Advaxis Company Details
-
14.9.2 Advaxis Anal Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Advaxis Anal Cancer Product and Service
-
14.10 Novartis
-
14.10.1 Novartis Company Details
-
14.10.2 Novartis Anal Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Novartis Anal Cancer Product and Service
-
14.11 Millennium Pharmaceuticals
-
14.11.1 Millennium Pharmaceuticals Company Details
-
14.11.2 Millennium Pharmaceuticals Anal Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Millennium Pharmaceuticals Anal Cancer Product and Service
-
14.12 Atara Biotherapeutics
-
14.12.1 Atara Biotherapeutics Company Details
-
14.12.2 Atara Biotherapeutics Anal Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Atara Biotherapeutics Anal Cancer Product and Service
-
14.13 Genticel
-
14.13.1 Genticel Company Details
-
14.13.2 Genticel Anal Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 Genticel Anal Cancer Product and Service
-
14.14 Bayer
-
14.14.1 Bayer Company Details
-
14.14.2 Bayer Anal Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
14.14.3 Bayer Anal Cancer Product and Service
-
14.15 Global BioPharma
-
14.15.1 Global BioPharma Company Details
-
14.15.2 Global BioPharma Anal Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
14.15.3 Global BioPharma Anal Cancer Product and Service
-
14.16 Merck?Co
-
14.16.1 Merck?Co Company Details
-
14.16.2 Merck?Co Anal Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
14.16.3 Merck?Co Anal Cancer Product and Service
-
14.17 Sun Pharma
-
14.17.1 Sun Pharma Company Details
-
14.17.2 Sun Pharma Anal Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
14.17.3 Sun Pharma Anal Cancer Product and Service
-
14.18 Cell Medica
-
14.18.1 Cell Medica Company Details
-
14.18.2 Cell Medica Anal Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
14.18.3 Cell Medica Anal Cancer Product and Service
-
14.19 Amgen Inc
-
14.19.1 Amgen Inc Company Details
-
14.19.2 Amgen Inc Anal Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
14.19.3 Amgen Inc Anal Cancer Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Anal Cancer
-
Figure Anal Cancer Picture
-
Table Global Anal Cancer Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Anal Cancer Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Anal Cancer Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Anal Cancer Consumption by Country (2017-2022)
-
Figure United States Anal Cancer Consumption and Growth Rate (2017-2022)
-
Table Europe Anal Cancer Consumption and Growth Rate (2017-2022)
-
Figure China Anal Cancer Consumption and Growth Rate (2017-2022)
-
Figure Japan Anal Cancer Consumption and Growth Rate (2017-2022)
-
Figure India Anal Cancer Consumption and Growth Rate (2017-2022)
-
Figure South Korea Anal Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Anal Cancer Consumption Forecast by Country (2022-2028)
-
Figure United States Anal Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Anal Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Anal Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Anal Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Anal Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Anal Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Fluorouracil Consumption and Growth Rate (2017-2022)
-
Figure Global Cisplatin Consumption and Growth Rate (2017-2022)
-
Figure Global Carboplatin Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Long-term care centers Consumption and Growth Rate (2017-2022)
-
Figure Global Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Fluorouracil Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cisplatin Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Carboplatin Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Long-term care centers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Anal Cancer Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Anal Cancer Export by Region (Top 5 Countries) (2017-2028)
-
Table Spectrum Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Spectrum Pharmaceuticals Anal Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
Table Spectrum Pharmaceuticals Anal Cancer Product and Service
-
Table PDS Biotechnology (Foundation Year, Company Profile and etc.)
-
Table PDS Biotechnology Anal Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
Table PDS Biotechnology Anal Cancer Product and Service
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Anal Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Anal Cancer Product and Service
-
Table Oryx (Foundation Year, Company Profile and etc.)
-
Table Oryx Anal Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
Table Oryx Anal Cancer Product and Service
-
Table Eli Lilly (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly Anal Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly Anal Cancer Product and Service
-
Table ??Ono Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table ??Ono Pharmaceutical Anal Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
Table ??Ono Pharmaceutical Anal Cancer Product and Service
-
Table Hospira (Foundation Year, Company Profile and etc.)
-
Table Hospira Anal Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
Table Hospira Anal Cancer Product and Service
-
Table ISA Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table ISA Pharmaceuticals Anal Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
Table ISA Pharmaceuticals Anal Cancer Product and Service
-
Table Advaxis (Foundation Year, Company Profile and etc.)
-
Table Advaxis Anal Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
Table Advaxis Anal Cancer Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Anal Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Anal Cancer Product and Service
-
Table Millennium Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Millennium Pharmaceuticals Anal Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
Table Millennium Pharmaceuticals Anal Cancer Product and Service
-
Table Atara Biotherapeutics (Foundation Year, Company Profile and etc.)
-
Table Atara Biotherapeutics Anal Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
Table Atara Biotherapeutics Anal Cancer Product and Service
-
Table Genticel (Foundation Year, Company Profile and etc.)
-
Table Genticel Anal Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
Table Genticel Anal Cancer Product and Service
-
Table Bayer (Foundation Year, Company Profile and etc.)
-
Table Bayer Anal Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer Anal Cancer Product and Service
-
Table Global BioPharma (Foundation Year, Company Profile and etc.)
-
Table Global BioPharma Anal Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
Table Global BioPharma Anal Cancer Product and Service
-
Table Merck?Co (Foundation Year, Company Profile and etc.)
-
Table Merck?Co Anal Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck?Co Anal Cancer Product and Service
-
Table Sun Pharma (Foundation Year, Company Profile and etc.)
-
Table Sun Pharma Anal Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sun Pharma Anal Cancer Product and Service
-
Table Cell Medica (Foundation Year, Company Profile and etc.)
-
Table Cell Medica Anal Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cell Medica Anal Cancer Product and Service
-
Table Amgen Inc (Foundation Year, Company Profile and etc.)
-
Table Amgen Inc Anal Cancer Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Inc Anal Cancer Product and Service
-
